Actually, the Saudi Sheikh did make the following statement to that effect that was included in the press release on Dec 22, 2020:

 “We are pleased with our discussions with Resverlogix and its entire team and believe in the recent Breakthrough Therapy Designation granted by the FDA; Apabetalone and its effect on cardiovascular, CKD, Alzheimer’s and COVID-19 as well as its contribution to the future of mankind,” said Sheikh Abdulgader.

Time will tell how this one turns out.

http://www.investmentpitch.com/video/1_eb4lc99n/Resverlogix-in-active-discussions-with-the-Kingdom-of-Moroccos-Ministry-of-Health-for-the-launch-of-COVID-19-clinical-studies-involving-apabetalone

Just saying ... Koo